Roivant Sciences Company
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Investors
Connections from
Total Funding:
2293000000.0
Acquisitions Number:
Made Acquisitions
Headquarters:
New York, New York, United States
Funding Status:
IPO
Employee Number:
501-1000
Estimated Revenue:
$10M to $50M
Last Funding Type:
Post-IPO Equity
Technology:
['BioTech & HealthTech', 'AI Infrastructure', 'Education, Research & SocialTech']
Last Funding Date:
2023-02-02
Investors Number:
15.0
Founded Date:
2014-05-01
Industry:
Medical BioTech